
Phase 2 trial finds bezisterim shows safety and symptom gains in long COVID, with strongest benefits for severe fatigue, PEM, and cognitive issues.
What does recent research have to say on video telemedicine?
Shira Fischer, MD, PhD, and her colleagues at RAND—Lori Uscher-Pines, PhD; Elizabeth Roth; and Joshua Breslau, PhD, ScD, MS—published an
Dr Fischer is a Physician Policy Researcher at the RAND Corporation.